Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion type Assertion NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_head.
- NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion description "[NRP2 is a robust biomarker for predicting response to IGF-IR therapy because prostate carcinomas that express NRP2 exhibit low levels of IGF-IR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_provenance.
- NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion evidence source_evidence_literature NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_provenance.
- NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion SIO_000772 22777769 NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_provenance.
- NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion wasDerivedFrom befree-20150227 NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_provenance.
- NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_assertion wasGeneratedBy ECO_0000203 NP806629.RAcBVDpDUb9MRIcwu6bc9Sp-Pev2vDtctIKxCQcZljoxM130_provenance.